Ergoteles’s Relmada Therapeutics RLMD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-27,100	Closed	-$66.7K	–	676
2023 Q2	$66.7K	Buy	+27,100	New	+$66.7K	﹤0.01%	940
2022 Q1	–	Sell	-91,500	Closed	-$2.06M	–	1578
2021 Q4	$2.06M	Buy	+91,500	New	+$2.06M	0.08%	252